Esperion Therapeutics, Inc. (ESPR)
2.935
-0.10
(-3.45%)
USD |
NASDAQ |
Jan 20, 11:16
Esperion Therapeutics Market Cap: 695.80M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals, Inc. | 844.27M |
| Palatin Technologies, Inc. | 16.07M |
| Theriva Biologics, Inc. | 6.313M |
| Oragenics, Inc. | 0.7818M |
| NanoViricides, Inc. | 20.88M |
Market Cap Related Metrics
| PS Ratio | 1.908 |
| Price | 2.935 |
| Earnings Yield | -18.26% |